期刊
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
卷 35, 期 3, 页码 633-653出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.hoc.2021.02.008
关键词
Precision medicine; Bladder cancer; Urothelial carcinoma; Targeted therapy; Biomarkers; Immunotherapy; Chemotherapy
资金
- Memorial Sloan Kettering's NIH/NCI Cancer Center Support Grant [P30 CA008748]
- NIH/NCI award [T32-CA009207]
- MSK's NCI SPORE in Bladder Cancer [P50 CA221745-01]
- DOD Congressionally Directed Medical Research Program Translational Team Science Award
- NCI Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)
分享论文
